DADA2 Disease
DADA2 Disease
Definition
DADA2 is a rare disease that runs in families. It causes ongoing swelling and irritation in blood vessels all over the body. Because blood vessels carry blood to every organ, DADA2 can affect many parts of the body at once, including the skin, brain, gut, and blood. Symptoms usually start in childhood, but some people are not diagnosed until they are adults.
Common Symptoms
Skin and blood vessels:
- A purple, net-like rash on the skin
- Fingers or toes that turn cold, pale, or blue in cold weather or stress
- Sores in the mouth
_________________________________________________________________________________
Brain and nerves:
- Stroke at a young age (before age 10), from a blocked or burst blood vessel in the brain
- Sudden weakness, numbness, or tingling in the arms or legs
_________________________________________________________________________________
Blood and immune system:
- Low blood cell counts, this can cause tiredness and pallor (low red cells), more infections (low white cells), or easy bruising and bleeding (low platelets)
- Getting sick often, or having low levels of the proteins that fight infection
- A swollen liver or spleen
_________________________________________________________________________________
Other:
- High blood pressure
- Liver damage or scarring over time
- Stomach and gut inflammation that looks similar to inflammatory bowel disease
- Slower growth or development in children
Less Common Symptoms
- Eye problems
- Kidney disease
- Blood cancers and lymphoma
- Severe bone marrow failure (when the bone marrow stops making enough blood cells)
Cause
DADA2 happens because of a change in a gene that normally tells the body how to make a substance called adenosine deaminase 2 (ADA2). Under normal conditions, ADA2 breaks down a molecule that builds up outside cells, and this keeps the immune system calm and balanced. When the gene is changed, the body does not make enough working ADA2. Without it, that molecule builds up and pushes immune cells into an overactive state. These overactive immune cells attack the walls of blood vessels, which is why swelling and irritation can affect so many organs at once.
Inheritance
DADA2 is passed down in an autosomal recessive pattern. This means a child needs two changed copies of the gene , one from each parent , to have the disease. Parents who carry just one changed copy are usually completely healthy themselves.
If both parents are carriers, for each pregnancy:
- About 1 in 4 children will have DADA2
- About 1 in 2 children will be healthy carriers, like their parents
- About 1 in 4 children will not inherit the gene change at all
Distribution
DADA2 is thought to affect 1 in 222,000 people, meaning about 35,000 people may have it worldwide, though many are likely undiagnosed. It's more common in families where parents are close blood relatives. It affects men and women equally, and some gene changes are more common in certain groups, such as Georgian-Jewish, Turkish, Finnish, and Dutch populations.
Diagnosis
Doctors confirm DADA2 with two main tests: a blood test that measures how well the ADA2 enzyme is working (it will be very low or missing), and a genetic test that checks for changes in both copies of the ADA2 gene. Other tests, like blood counts, infection-fighting protein levels, and brain scans (MRI) , help check how much the disease has affected the body. Finding it early is important to help prevent strokes and other serious problems.
Management
Because DADA2 can affect so many parts of the body, care usually involves a team of different doctors, including:
- Joint and blood vessel inflammation specialist (rheumatologist)
- Immune system specialist (immunologist)
- Blood disorder specialist (hematologist)
- Brain and nerve specialist (neurologist)
- Stomach and gut specialist (gastroenterologist)
- Liver specialist (hepatologist)
- Eye specialist (ophthalmologist)
- Physical and occupational therapist, to help with recovery and daily activities after a stroke or nerve damage
- Genetic counselor, to explain inheritance and help with family planning
- Social worker, to connect families with support services
Regular check-ups every 3–6 months with this care team are important for managing the disease over time. Patients are usually placed on anti-inflammatory treatment and corticosteroids but cure lies in stem cell transplantation.
Resources & Support
- The DADA2 Foundation (dada2.org) an international group of experts from 18 countries who created shared care guidelines for DADA2, and a place for patients and families to find support and information.
- National Organization for Rare Disorders (NORD) general DADA2 overview.
- Orphanet DADA2 disease summary.
Credits
- Writer: Fatima Fawzi
- Reviewer: Dr. Anas Abu Hazeem
References
- Lee PY, Davidson BA, Abraham RS, et al. Evaluation and Management of Deficiency of Adenosine Deaminase 2: An International Consensus Statement. JAMA Network Open. 2023.
- Aksentijevich I, Sampaio Moura N, Barron K. Adenosine Deaminase 2 Deficiency. GeneReviews. 2019.
- Jee H, Huang Z, Baxter S, et al. Comprehensive Analysis of ADA2 Genetic Variants and Estimation of Carrier Frequency Driven by a Function-Based Approach. J Allergy Clin Immunol. 2022.
- Moens L, Hershfield M, Arts K, Aksentijevich I, Meyts I. Human adenosine deaminase 2 deficiency: A multi-faceted inborn error of immunity. Immunol Rev. 2019.
- Grim A, Veiga KR, Saad N. Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment. Rheum Dis Clin North Am. 2023.
- Mo A, Donatelli S, Benson LA, Lee PY, Rivkin MJ. Child Neurology: Recurrent Brainstem Strokes and Aphthous Ulcers in a Child With Mutations in the ADA2 Gene. Neurology. 2021.
- The DADA2 Foundation. dada2.org.
Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Always consult with qualified healthcare providers for diagnosis and treatment.